Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiro Okami

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Interdisciplinary Cardiovascular and Thoracic Surgery|September 25, 2025
Intraoperative diaphragmatic plication during initial surgery with phrenic nerve resectionTomomi Isono, Mitsunori Ohta, Ryu Kanzaki, et al.
Cancers|October 27, 2022
Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010Yoshikane Yamauchi, Masafumi Kawamura, Jiro Okami, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2020
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry StudyKoichi Fukumoto, Shoichi Mori, Yasushi Shintani, et al.
The Annals of Thoracic Surgery|July 3, 2020
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer CasesKenichi Suda, Tetsuya Mitsudomi, Yasushi Shintani, et al.
Cancer Science|December 23, 2025
Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From Checkmate 77TFumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara, et al.
Cancer Science|December 15, 2023
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816Tetsuya Mitsudomi, Hiroyuki Ito, Morihito Okada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2016
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter StudyRyutaro Kakinuma, Masayuki Noguchi, Kazuto Ashizawa, et al.
Japanese Journal of Clinical Oncology|August 26, 2023
Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from JapanHiroyuki Adachi, Aya Saito, Yasushi Shintani, et al.
Lancet (London, England)|April 24, 2022
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialHisashi Saji, Morihito Okada, Masahiro Tsuboi, et al.
Cancer Genetics|January 10, 2020
Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution modelKei Kunimasa, Yosuke Hirotsu, Harumi Nakamura, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Interdisciplinary Cardiovascular and Thoracic Surgery|September 25, 2025
Intraoperative diaphragmatic plication during initial surgery with phrenic nerve resectionTomomi Isono, Mitsunori Ohta, Ryu Kanzaki, et al.
Cancers|October 27, 2022
Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010Yoshikane Yamauchi, Masafumi Kawamura, Jiro Okami, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2020
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry StudyKoichi Fukumoto, Shoichi Mori, Yasushi Shintani, et al.
The Annals of Thoracic Surgery|July 3, 2020
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer CasesKenichi Suda, Tetsuya Mitsudomi, Yasushi Shintani, et al.
Cancer Science|December 23, 2025
Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From Checkmate 77TFumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara, et al.
Cancer Science|December 15, 2023
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816Tetsuya Mitsudomi, Hiroyuki Ito, Morihito Okada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2016
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter StudyRyutaro Kakinuma, Masayuki Noguchi, Kazuto Ashizawa, et al.
Japanese Journal of Clinical Oncology|August 26, 2023
Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from JapanHiroyuki Adachi, Aya Saito, Yasushi Shintani, et al.
Lancet (London, England)|April 24, 2022
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trialHisashi Saji, Morihito Okada, Masahiro Tsuboi, et al.
Cancer Genetics|January 10, 2020
Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution modelKei Kunimasa, Yosuke Hirotsu, Harumi Nakamura, et al.
Pageof 17